← Open Payments lookup

BALBIR KAUR: Open Payments

NPI 1740960491 · VINELAND, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$441 in 22 payments from 10 companies in 2025. Trend: 2023 $34 · 2024 $391 · 2025 $441

Food & beverage: $357Education: $84
CompanyPaymentsAmount
Janssen Biotech, Inc.4$142
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$99
Daiichi Sankyo Inc.3$48
Madrigal Pharmaceuticals2$37
Phathom Pharmaceuticals, Inc.2$25
GENZYME CORPORATION1$20
Lilly USA, LLC1$19
Celltrion USA Inc.1$19
ABBVIE INC.1$17
Takeda Pharmaceuticals U.S.A., Inc.1$14

Products named: TREMFYA, XIFAXAN, INJECTAFER, REZDIFFRA, VOQUEZNA, DUPIXENT, OMVOH, VEGZELMA.

Industry payments across NJ — which companies pay providers there.